Blaze Bioscience Stock
Blaze Bioscience develops and commercializes products that assist surgeons to treat cancer patients.
Sign up today and learn more about Blaze Bioscience Stock
Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.
About Blaze Bioscience Stock
Blaze Bioscience is a Seattle-based, privately-held biotechnology company dedicated to developing products that assist surgeons in their quest to improve the lives of cancer patients. The company was founded in 2010 to develop and commercialize the Tumor Paint technology. Tumor Paint provides real-time, highresolution intraoperative visualization of cancer cells, enabling better detection and more complete and precise surgical resection of cancer. The first Tumor Paint product candidate, which is a combination of a targeting peptide and a fluorescent beacon, is under development for multiple solid tumors.
Funding History
| June 2012 | $6.4M |
|---|---|
| June 2015 | $9.7M |
| April 2016 | $0 |
| October 2017 | $16.1M |
| May 2018 | $3.0M |
Management
Founder
James Olson
President & CEO
Heather Franklin
Senior Director of Process Development & Manufacturing
Claudia Jochheim
Vice President, Research & Project Management
Julia Novak
Vice President, Finance & Operations
Mila Lobanova
EquityZen does not have an affiliation with, formal relationship with, or endorsement from any companies featured above. This profile is based on publicly available information and is intended to be informative in nature.
Some data provided by Crunchbase
EquityZen Recognized As:
